No Data
No Data
RBC Capital Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $105
Boston Sci Issues Safety Recall for POLARx Cryoablation Catheters
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Express News | Boston Scientific Shares Extend Losses, Last Down 1.7% at $88.90
Express News | FDA: There Have Been Seven Reported Injuries & Four Reports of Death Related to Boston Scientific's Polarx Cryoablation Balloon Catheters
Unlock the Full List